Search
Filters
Clear All
  • 5

Phase

  • 1
  • 4
  • 5
  • 5

Found 5 jean-molleston-md trials

A listing of jean-molleston-md medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

TReatment for ImmUne Mediated PathopHysiology (TRIUMPH)

J
Jean Molleston, MD
1 year - 18 years
All genders
Phase 2
Interventional
TReatment for ImmUne Mediated PathopHysiology (TRIUMPH) is a multi-center, three arm,domized, controlled trial of immunosuppressive therapy for children with acute liverure. The study will determine if suppressing inflammatory responses with eitherds or equine anti-thymocyte globulin therapy improves survival for children withhis rare, life-threatening condition.
Learn More

Liver Stiffness in Patients with Underlying Polycystic Kidney Disorders.

J
Jean Molleston, MD
3 years - 65 years
All genders
Use Fibroscan to determine thevalence of CHF in an ADPKD population and the incidence over a four-yeard in these patients. Use Fibroscan to determine thevalence of congenital hepatic fibrosis in an ARPKD population Use fibroscan to determine thevalence of fibrotic liver disease in patients with other cystic kidneydiseases such as …
Learn More

Understanding Biliary Atresia in Kids

J
Jean Molleston, MD
6 months - 20 years
All genders
This study investigates biliary atresia, a condition affecting the liver in infants and children. Biliary atresia is a disease where the bile ducts become blocked, which can lead to liver damage. The purpose of this study is to collect medical information to better understand the natural history and causes of …
Learn More

Longitudinal Study of Genetic Causes of Intrahepatic Cholestasis (LOGIC) (LOGIC)

J
Jean Molleston, MD
25 years or below
All genders
Observational
Cholestasis is a condition in which bile is not properly transported from the liver to the. Cholestasis can be caused by an array of childhood diseases, including the genetic diseases Alagille syndrome (ALGS), alpha-1 antitrypsin (a-1AT) deficiency, bile acidynthesis and metabolism defects, and progressive familial intrahepatic cholestasis (PFIC) or benign …
Learn More

A Randomized Double-Blind Evaluation of the Pharmacokinetics Safety and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Adolescents with Chronic Hepatitis B Virus Infection

J
Jean Molleston, MD
100 years or below
All genders
The purpose of this study is to evaluate the safety, tolerability, and effectiveness of TAF against the Hepatitis B Virus in all of the enrolled adolescent subjects.
Learn More